As such, under consideration of our sensitivity analyses, our results suggest two possibilities in which (1) APOE ε4 carriership increases vulnerability through lower levels of cognitive resilience that otherwise might protect against cognitive decline or (2) APOE ε4 affects cognition independently of neurodegeneration measurable on MRI. This evidence concerns the gene APOE and Mental deterioration.